These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16960917)

  • 1. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.
    Peleg AY; Weerarathna T; McCarthy JS; Davis TM
    Diabetes Metab Res Rev; 2007 Jan; 23(1):3-13. PubMed ID: 16960917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.
    Moutschen MP; Scheen AJ; Lefebvre PJ
    Diabete Metab; 1992; 18(3):187-201. PubMed ID: 1397473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-acquired infections in type 2 diabetic patients and their nondiabetic partners. The Fremantle Diabetes Study.
    Davis TM; Weerarathne T; Foong Y; Mason C; Davis WA
    J Diabetes Complications; 2005; 19(5):259-63. PubMed ID: 16112500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol.
    Shulman R; Finney SJ; O'Sullivan C; Glynne PA; Greene R
    Crit Care; 2007; 11(4):R75. PubMed ID: 17623086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the innate immune response in hospital- versus community-acquired infection in febrile medical patients.
    Groeneveld AB; Hack CE
    Int J Infect Dis; 2008 Nov; 12(6):660-70. PubMed ID: 18514561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus as a risk factor for nosocomial pneumonia and associated mortality.
    Vardakas KZ; Siempos II; Falagas ME
    Diabet Med; 2007 Oct; 24(10):1168-71. PubMed ID: 17888136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic complications and glycaemic control in remote North Africa.
    Gill G; Gebrekidan A; English P; Wile D; Tesfaye S
    QJM; 2008 Oct; 101(10):793-8. PubMed ID: 18687702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus: anaesthetic management.
    Robertshaw HJ; Hall GM
    Anaesthesia; 2006 Dec; 61(12):1187-90. PubMed ID: 17090240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
    Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical operations in diabetics].
    Bottermann P
    MMW Fortschr Med; 2005 Sep; 147(37):51-4. PubMed ID: 16193879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningitis in diabetic patients.
    Muli JM; Seckova S; Sladeckova V; Steno J; Adamcova J; Rabarova L; Takacova M; Polonova J; Dudasova T; Pauerova K; Namulanda V; Okoth V; Juma O; Diana E; Johnson MJ; Deadline J; Bartkovjak M; Kolenova A; Taziarova M; Benca J; Njambi Z
    Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():28-9. PubMed ID: 18030274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
    Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control and antibody status among patients with newly diagnosed Type 1 diabetes.
    Hickey D; Joshy G; Dunn P; Simmons D; Lawrenson R
    N Z Med J; 2007 Sep; 120(1262):U2732. PubMed ID: 17891220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host defenses and susceptibility to infection in patients with diabetes mellitus.
    McMahon MM; Bistrian BR
    Infect Dis Clin North Am; 1995 Mar; 9(1):1-9. PubMed ID: 7769211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations in natural immunity and risk of infection in patients with diabetes mellitus].
    Moutschen M
    Rev Med Liege; 2005; 60(5-6):541-4. PubMed ID: 16035324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
    Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
    Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for increased mortality from hospital-acquired versus community-acquired infections in febrile medical patients.
    Groeneveld AB
    Am J Infect Control; 2009 Feb; 37(1):35-42. PubMed ID: 19171248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.